J&J said that serious adverse events , such as accidents or illnesses, are"an expected part of any clinical study, especially large studies."
J&J's announcement was followed Tuesday afternoon by news that Eli Lilly had also paused a trial of a coronavirus antibody treatment out of safety concerns.The companies' announcements were also a drag on the broader market, said Briefing.com analyst Patrick O'Hare. Travel-related stocks, which are seen as major beneficiaries of a coronavirus vaccine, suffered especially big drops.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
'Blue wave' US election expectations trigger green stocks frenzyGrowing expectations of a strong Democratic victory in U.S. elections have prompted investors to snap up renewable energy stocks, amplifying a ...
Fonte: ChannelNewsAsia - 🏆 6. / 66 Consulte Mais informação »
Nasdaq jumps 2.6 per cent as tech leads US stocks to close higherNEW YORK (AFP) - Tech shares led US stocks higher Monday, with Apple surging ahead of a new iPhone launch as investors shrugged off the stalemate over US stimulus talks in Washington.. Read more at straitstimes.com.
Fonte: The Straits Times - 🏆 8. / 63 Consulte Mais informação »
Tokyo: Stocks close higher after US rallies[TOKYO] Tokyo stocks closed marginally higher in sluggish trading on Tuesday following rallies on Wall Street, as investors remained on the sidelines ahead of Japan's corporate results season. Read more at The Business Times.
Fonte: BusinessTimes - 🏆 15. / 51 Consulte Mais informação »